• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BBK Worldwide launches Health Info Gizmo app

BBK Worldwide launches Health Info Gizmo app

May 8, 2013
CenterWatch Staff

BBK Worldwide, a provider of patient recruitment technology, products and services, has launched Health Info Gizmo, a mobile vehicle used to inform, educate and engage patient audiences about clinical trials, and in the process, foster long-term relationships between advocacy groups and the pharmaceutical industry.

By leveraging the power of collaboration, the Gizmo provides clinical trial sponsors with opportunities to engage and partner with patient advocacy organizations to advance clinical research.

“Advocacy groups are hesitant to assist in the promotion of clinical trials for fear that their involvement may smatter of endorsement of one company or therapeutic direction over another,” said Aaron B. Fleishman, leader of BBK’s social innovation group. “The interesting dilemma is that, more than ever, advocacy groups want to help their constituencies by encouraging awareness of clinical trials.”

This mobile web application provides the platform that, among other attributes, frees advocacy groups to engage in the clinical trial dialogue. Most compelling for these organizations is that the Gizmo’s sole directive is to help patients make informed decisions, not persuade them to consider one option over another.

“If potential study participants are more aware of clinical trials and they can understand how to evaluate them as a potential benefit for not only themselves but potentially their whole disease community through the information gathered from the trial, then everybody wins,” said Blair Van Brunt, executive director of the Shwachman-Diamond Syndrome Foundation. The foundation is a national, nonprofit, patient advocacy organization that supports research towards a cure for Shwachman-Diamond syndrome and efforts to improve medical management of its symptoms.

Within the Gizmo are four user-friendly components highlighting areas of interest most pertinent to someone who is managing a given therapeutic condition. “Speak Out” includes video and podcast interviews of patient advocates—moving excerpts that are designed to humanize the app’s experience for the user. “Get Involved” is a section that promotes health and fundraising events that encourage participation and community spirit. “Learn More” provides a host of resources for users, while “Studies” provides a condition-specific display in real-time that makes finding clinical trials faster and easier.

In addition, the Gizmo provides a fundraising opportunity for local advocacy groups, as BBK has ensured that for each person who downloads the app, a corresponding dollar amount is given to a local advocacy group.

“BBK’s approach is based on years of experience collaborating with advocacy groups and partnering for a shared cause. If you don’t establish trust and goodwill with advocacy groups at the outset, efforts to engage can be perceived as self-serving and fleeting,” said Fleishman.

BBK launched an award-winning program for diabetes, “Calling All Types,” which served as the research pilot for the Gizmo product line.

“Clinical trials was ranked number one by a majority of campaign respondents as the most important consideration for them in responding to BBK’s outreach efforts—way ahead of disease awareness or care guidelines,” said Fleishman.

BBK also deploys the Gizmo on trial-specific promotional campaigns as the company believes that when a patient responds to study advertising, completes a survey and does not prequalify for a specific study, he or she should be provided with alternatives for consideration.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing